|
1
|
Aseyev O, Ribeiro JM and Cardoso F: Review
on the clinical use of eribulin mesylate for the treatment of
breast cancer. Expert Opin Pharmacother. 17:589–600. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cornejo-Moreno BA, Uribe-Escamilla D and
Salamanca-Gómez F: Breast cancer genes: Looking for BRACA's lost
brother. Isr Med Assoc J. 16:787–792. 2014.
|
|
3
|
Koo T and Kim IA: Brain metastasis in
human epidermal growth factor receptor 2-positive breast cancer:
From biology to treatment. Radiat Oncol J. 34:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mouh FZ, Mzibri ME, Slaoui M and Amrani M:
Recent progress in triple negative breast cancer research. Asian
Pac J Cancer Prev. 17:1595–1608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hurvitz S and Mead M: Triple-negative
breast cancer: Advancements in characterization and treatment
approach. Curr Opin Obstet Gynecol. 28:59–69. 2016.
|
|
6
|
Zeichner SB, Terawaki H and Gogineni K: A
review of systemic treatment in metastatic triple-negative breast
cancer. Breast Cancer (Auckl). 10:25–36. 2016.
|
|
7
|
Wang Y, Cao S and Chen Y: Molecular
treatment of different breast cancers. Anticancer Agents Med Chem.
15:701–720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomao F, Papa A, Zaccarelli E, Rossi L,
Caruso D, Minozzi M, Vici P, Frati L and Tomao S: Triple-negative
breast cancer: New perspectives for targeted therapies. Onco
Targets Ther. 8:177–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gilani RA, Phadke S, Bao LW, Lachacz EJ,
Dziubinski ML, Brandvold KR, Steffey ME, Kwarcinski FE, Graveel CR,
Kidwell KM, et al: UM-164: A potent c-Src/38 kinase inhibitor with
in vivo activity against triple-negative breast cancer. Clin Cancer
Res. 22:5087–5096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng B, Yang L, Wen C, Huang X, Xu C, Lee
KH and Xu J: Curcumin analog L3 alleviates diabetic atherosclerosis
by multiple effects. Eur J Pharmacol. 775:22–34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferreira N, Saraiva MJ and Almeida MR:
Natural polyphenols as modulators of TTR amyloidogenesis: in vitro
and in vivo evidences towards therapy. Amyloid. 19(Suppl 1): 39–42.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vilekar P, King C, Lagisetty P, Awasthi V
and Awasthi S: Antibacterial activity of synthetic curcumin
derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and
EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA).
Appl Biochem Biotechnol. 172:3363–3373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhutani MK, Bishnoi M and Kulkarni SK:
Anti-depressant like effect of curcumin and its combination with
piperine in unpredictable chronic stress-induced behavioral,
biochemical and neurochemical changes. Pharmacol Biochem Behav.
92:39–43. 2009. View Article : Google Scholar
|
|
14
|
Cianciulli A, Calvello R, Porro C, Trotta
T, Salvatore R and Panaro MA: PI3k/Akt signalling pathway plays a
crucial role in the anti-inflammatory effects of curcumin in
LPS-activated microglia. Int Immunopharmacol. 36:282–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choudhury AK, Raja S, Mahapatra S,
Nagabhushanam K and Majeed M: Synthesis and evaluation of the
anti-oxidant capacity of curcumin glucuronides, the major curcumin
metabolites. Antioxidants. 4:750–767. 2015. View Article : Google Scholar
|
|
16
|
Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L,
Weng J and Yu Z: Curcumin attenuates urinary excretion of albumin
in type II diabetic patients with enhancing nuclear factor
erythroid-derived 2-like 2 (Nrf2) system and repressing
inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes.
123:360–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee D, Kim IY, Saha S and Choi KS:
Paraptosis in the anti-cancer arsenal of natural products.
Pharmacol Ther. 162:120–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Borges GA, Rêgo DF, Assad DX, Coletta RD,
De Canto Luca G and Guerra EN: In vivo and in vitro effects of
curcumin on head and neck carcinoma: A systematic review. J Oral
Pathol Med. 46:3–20. 2017. View Article : Google Scholar
|
|
19
|
Sordillo PP and Helson L: Curcumin and
cancer stem cells: Curcumin has asymmetrical effects on cancer and
normal stem cells. Anticancer Res. 35:599–614. 2015.PubMed/NCBI
|
|
20
|
Iqbal B, Ghildiyal A, Sahabjada, Singh S,
Arshad M, Mahdi AA and Tiwari S: Antiproliferative and apoptotic
effect of curcumin and TRAIL (TNF related apoptosis inducing
ligand) in chronic myeloid leukaemic cells. J Clin Diagn Res.
10:XC01–XC05. 2016.PubMed/NCBI
|
|
21
|
Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu
R, Yu H, Xu Q and Sun Y: Induction of ROS-independent DNA damage by
curcumin leads to G2/M cell cycle arrest and apoptosis
in human papillary thyroid carcinoma BCPAP cells. Food Funct.
7:315–325. 2016. View Article : Google Scholar
|
|
22
|
Huang YT, Lin YW, Chiu HM and Chiang BH:
Curcumin induces apoptosis of colorectal cancer stem cells by
coupling with CD44 marker. J Agric Food Chem. 64:2247–2253. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kantara C, O'Connell M, Sarkar S, Moya S,
Ullrich R and Singh P: Curcumin promotes autophagic survival of a
subset of colon cancer stem cells, which are ablated by
DCLK1-siRNA. Cancer Res. 74:2487–2498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji JL, Huang XF and Zhu HL: Curcumin and
its formulations: Potential anti-cancer agents. Anticancer Agents
Med Chem. 12:210–218. 2012. View Article : Google Scholar
|
|
25
|
Shehzad A, Wahid F and Lee YS: Curcumin in
cancer chemo-prevention: Molecular targets, pharmacokinetics,
bioavailability, and clinical trials. Arch Pharm (Weinheim).
343:489–499. 2010. View Article : Google Scholar
|
|
26
|
Chang PY, Peng SF, Lee CY, Lu CC, Tsai SC,
Shieh TM, Wu TS, Tu MG, Chen MY and Yang JS: Curcumin-loaded
nanoparticles induce apoptotic cell death through regulation of the
function of MDR1 and reactive oxygen species in cisplatin-resistant
CAR human oral cancer cells. Int J Oncol. 43:1141–1150. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Douglass BJ and Clouatre DL: Beyond yellow
curry: Assessing commercial curcumin absorption technologies. J Am
Coll Nutr. 34:347–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsieh MT, Chang LC, Hung HY, Lin HY, Shih
MH, Tsai CH, Kuo SC and Lee KH: New bis(hydroxymethyl) alkanoate
curcuminoid derivatives exhibit activity against triple-negative
breast cancer in vitro and in vivo. Eur J Med Chem. 131:141–151.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng SF, Lee CY, Hour MJ, Tsai SC, Kuo DH,
Chen FA, Shieh PC and Yang JS: Curcumin-loaded nanoparticles
enhance apoptotic cell death of U2OS human osteosarcoma cells
through the Akt-Bad signaling pathway. Int J Oncol. 44:238–246.
2014. View Article : Google Scholar
|
|
30
|
Liao CL, Lai KC, Huang AC, Yang JS, Lin
JJ, Wu SH, Gibson Wood W, Lin JG and Chung JG: Gallic acid inhibits
migration and invasion in human osteosarcoma U-2 OS cells through
suppressing the matrix metalloproteinase-2/-9, protein kinase B
(PKB) and PKC signaling pathways. Food Chem Toxicol. 50:1734–1740.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai SC, Lu CC, Lee CY, Lin YC, Chung JG,
Kuo SC, Amagaya S, Chen FN, Chen MY, Chan SF, et al: AKT
serine/threonine protein kinase modulates bufalin-triggered
intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
Int J Oncol. 41:1683–1692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu CY, Yang JS, Huang SM, Chiang JH, Chen
MH, Huang LJ, Ha HY, Fushiya S and Kuo SC: Smh-3 induces
G2/M arrest and apoptosis through calcium-mediated
endoplasmic reticulum stress and mitochondrial signaling in human
hepatocellular carcinoma Hep3B cells. Oncol Rep. 29:751–762. 2013.
View Article : Google Scholar
|
|
33
|
Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC
and Chung JG: MJ-29 inhibits tubulin polymerization, induces
mitotic arrest, and triggers apoptosis via cyclin-dependent kinase
1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J
Pharmacol Exp Ther. 334:477–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang JS, Lin CA, Lu CC, Wen YF, Tsai FJ
and Tsai SC: Carboxamide analog ITR-284 evokes apoptosis and
inhibits migration ability in human lung adenocarcinoma A549 cells.
Oncol Rep. 37:1786–1792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ho CC, Huang AC, Yu CS, Lien JC, Wu SH,
Huang YP, Huang HY, Kuo JH, Liao WY, Yang JS, et al: Ellagic acid
induces apoptosis in TSGH8301 human bladder cancer cells through
the endoplasmic reticulum stress- and mitochondria-dependent
signaling pathways. Environ Toxicol. 29:1262–1274. 2014.
|
|
36
|
Yuan CH, Horng CT, Lee CF, Chiang NN, Tsai
FJ, Lu CC, Chiang JH, Hsu YM, Yang JS and Chen FA: Epigallocatechin
gallate sensitizes cisplatin-resistant oral cancer CAR cell
apoptosis and autophagy through stimulating AKT/STAT3 pathway and
suppressing multidrug resistance 1 signaling. Environ Toxicol.
32:845–855. 2017. View Article : Google Scholar
|
|
37
|
Chiang JH, Yang JS, Lu CC, Hour MJ, Chang
SJ, Lee TH and Chung JG: Newly synthesized quinazolinone HMJ-38
suppresses angiogenetic responses and triggers human umbilical vein
endo-thelial cell apoptosis through p53-modulated Fas/death
receptor signaling. Toxicol Appl Pharmacol. 269:150–162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang WW, Chiu YJ, Fan MJ, Lu HF, Yeh HF,
Li KH, Chen PY, Chung JG and Yang JS: Kaempferol induced apoptosis
via endoplasmic reticulum stress and mitochondria-dependent pathway
in human osteosarcoma U-2 OS cells. Mol Nutr Food Res.
54:1585–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu CC, Yang JS, Chiang JH, Hour MJ, Lin
KL, Lee TH and Chung JG: Cell death caused by quinazolinone HMJ-38
challenge in oral carcinoma CAL 27 cells: Dissections of
endoplasmic reticulum stress, mitochondrial dysfunction and tumor
xenografts. Biochim Biophys Acta. 1840:2310–2320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
King YA, Chiu YJ, Chen HP, Kuo DH, Lu CC
and Yang JS: Endoplasmic reticulum stress contributes to arsenic
trioxide-induced intrinsic apoptosis in human umbilical and bone
marrow mesenchymal stem cells. Environ Toxicol. 31:314–328. 2016.
View Article : Google Scholar
|
|
41
|
Kuo YJ, Yang JS, Lu CC, Chiang SY, Lin JG
and Chung JG: Ethanol extract of Hedyotis diffusa willd upregulates
G0/G1 phase arrest and induces apoptosis in human leukemia cells by
modulating caspase cascade signaling and altering associated genes
expression was assayed by cDNA microarray. Environ Toxicol.
30:1162–1177. 2015. View Article : Google Scholar
|
|
42
|
Wu RS, Liu KC, Tang NY, Chung HK, Ip SW,
Yang JS and Chung JG: cDNA microarray analysis of the gene
expression of murine leukemia RAW 264.7 cells after exposure to
propofol. Environ Toxicol. 28:471–478. 2013. View Article : Google Scholar
|
|
43
|
Guan F, Ding Y, Zhang Y, Zhou Y, Li M and
Wang C: Curcumin suppresses proliferation and migration of
MDA-MB-231 breast cancer cells through autophagy-dependent Akt
degradation. PLoS One. 11:e01465532016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dorée M and Hunt T: From Cdc2 to Cdk1:
When did the cell cycle kinase join its cyclin partner? J Cell Sci.
115:2461–2464. 2002.PubMed/NCBI
|
|
45
|
Chen ZQ, Jie X and Mo ZN: Curcumin
inhibits growth, induces G1 arrest and apoptosis on human prostatic
stromal cells by regulating Bcl-2/Bax. Zhongguo Zhong Yao Za Zhi.
33:2022–2025. 2008.In Chinese. PubMed/NCBI
|
|
46
|
Srivastava RK, Chen Q, Siddiqui I, Sarva K
and Shankar S: Linkage of curcumin-induced cell cycle arrest and
apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).
Cell Cycle. 6:2953–2961. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cheng C, Jiao JT, Qian Y, Guo XY, Huang J,
Dai MC, Zhang L, Ding XP, Zong D and Shao JF: Curcumin induces G2/M
arrest and triggers apoptosis via FoxO1 signaling in U87 human
glioma cells. Mol Med Rep. 13:3763–3770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Berrak O, Akkoc Y, Arisan ED, Coker-Gurkan
A, Obakan-Yerlikaya P and Palavan-Unsal N: The inhibition of PI3K
and NFkappaB promoted curcumin-induced cell cycle arrest at G2/M
via altering polyamine metabolism in Bcl-2 overexpressing MCF-7
breast cancer cells. Biomed Pharmacother. 77:150–160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Negroni A, Cucchiara S and Stronati L:
Apoptosis, necrosis, and necroptosis in the gut and intestinal
homeostasis. Mediators Inflamm. 2015:2507622015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang Y, Jiang G, Zhang P and Fan J:
Programmed cell death and its role in inflammation. Mil Med Res.
2:122015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Friesen C, Fulda S and Debatin KM:
Cytotoxic drugs and the CD95 pathway. Leukemia. 13:1854–1858. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang YS, Shen Q and Li J: Traditional
Chinese medicine targeting apoptotic mechanisms for esophageal
cancer therapy. Acta Pharmacol Sin. 37:295–302. 2016. View Article : Google Scholar :
|
|
53
|
Tameire F, Verginadis II and Koumenis C:
Cell intrinsic and extrinsic activators of the unfolded protein
response in cancer: Mechanisms and targets for therapy. Semin
Cancer Biol. 33:3–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ferri KF and Kroemer G: Organelle-specific
initiation of cell death pathways. Nat Cell Biol. 3:E255–E263.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dong Z, Liang S, Hu J, Jin W, Zhan Q and
Zhao K: Autophagy as a target for hematological malignancy therapy.
Blood Rev. 30:369–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gupta SC, Kismali G and Aggarwal BB:
Curcumin, a component of turmeric: From farm to pharmacy.
Biofactors. 39:2–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ye MX, Li Y, Yin H and Zhang J: Curcumin:
Updated molecular mechanisms and intervention targets in human lung
cancer. Int J Mol Sci. 13:3959–3978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sánchez-Martínez C, Gelbert LM, Lallena MJ
and de Dios A: Cyclin dependent kinase (CDK) inhibitors as
anticancer drugs. Bioorg Med Chem Lett. 25:3420–3435. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kozakowska M, Szade K, Dulak J and
Józkowicz A: Role of heme oxygenase-1 in postnatal differentiation
of stem cells: a possible cross-talk with microRNAs. Antioxid Redox
Signal. 20:1827–1850. 2014. View Article : Google Scholar :
|
|
60
|
Murakami A: Dose-dependent functionality
and toxicity of green tea polyphenols in experimental rodents. Arch
Biochem Biophys. 557:3–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zheng KM, Zhang J, Zhang CL, Zhang YW and
Chen XC: Curcumin inhibits appoptosin-induced apoptosis via
upregulating heme oxygenase-1 expression in SH-SY5Y cells. Acta
Pharmacol Sin. 36:544–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cremers NA, Lundvig DM, van Dalen SC,
Schelbergen RF, van Lent PL, Szarek WA, Regan RF, Carels CE and
Wagener FA: Curcumin-induced heme oxygenase-1 expression prevents
H2O2 induced cell death in wild type and heme
oxygenase-2 knockout adipose-derived mesenchymal stem cells. Int J
Mol Sci. 15:17974–17999. 2014. View Article : Google Scholar : PubMed/NCBI
|
